Arrowhead Pharmaceuticals Stock Market Value
| ARWR Stock | USD 15.36 0.29 1.92% |
| Symbol | Arrowhead |
Arrowhead Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.098 | Earnings Share (5.15) | Revenue Per Share | Quarterly Revenue Growth (0.30) | Return On Assets |
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Arrowhead Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arrowhead Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arrowhead Pharmaceuticals.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Arrowhead Pharmaceuticals on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Arrowhead Pharmaceuticals or generate 0.0% return on investment in Arrowhead Pharmaceuticals over 90 days. Arrowhead Pharmaceuticals is related to or competes with Wave Life, CytomX Therapeutics, Assembly Biosciences, Biomarin Pharmaceutical, Incyte, Ionis Pharmaceuticals, and Apellis Pharmaceuticals. Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States More
Arrowhead Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arrowhead Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arrowhead Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 19.61 | |||
| Value At Risk | (6.35) | |||
| Potential Upside | 4.71 |
Arrowhead Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arrowhead Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arrowhead Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Arrowhead Pharmaceuticals historical prices to predict the future Arrowhead Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.33) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arrowhead Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arrowhead Pharmaceuticals Backtested Returns
Arrowhead Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15 % return per unit of risk over the last 3 months. Arrowhead Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arrowhead Pharmaceuticals' Risk Adjusted Performance of (0.14), mean deviation of 2.72, and Standard Deviation of 3.53 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.81, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Arrowhead Pharmaceuticals will likely underperform. At this point, Arrowhead Pharmaceuticals has a negative expected return of -0.55%. Please make sure to confirm Arrowhead Pharmaceuticals' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Arrowhead Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.24 |
Weak reverse predictability
Arrowhead Pharmaceuticals has weak reverse predictability. Overlapping area represents the amount of predictability between Arrowhead Pharmaceuticals time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arrowhead Pharmaceuticals price movement. The serial correlation of -0.24 indicates that over 24.0% of current Arrowhead Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | -0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 3.24 |
Arrowhead Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Arrowhead Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Arrowhead Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Arrowhead Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Arrowhead Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Arrowhead Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Arrowhead Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Arrowhead Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Arrowhead Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Arrowhead Pharmaceuticals Lagged Returns
When evaluating Arrowhead Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Arrowhead Pharmaceuticals stock have on its future price. Arrowhead Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Arrowhead Pharmaceuticals autocorrelation shows the relationship between Arrowhead Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Arrowhead Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Arrowhead Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arrowhead Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Arrowhead Stock
Moving against Arrowhead Stock
The ability to find closely correlated positions to Arrowhead Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arrowhead Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arrowhead Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arrowhead Pharmaceuticals to buy it.
The correlation of Arrowhead Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arrowhead Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arrowhead Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arrowhead Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.